NEULAND LABORATORIES
Back to All Ratios
|
NEULAND LABORATORIES Last 5 Year Cash Earnings per Share (CEPS) History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| CEPS(Rs) | 253.82 | 280.42 | 168.59 | 87.97 | 93.78 |
What is the latest Cash Earnings per Share (CEPS) ratio of NEULAND LABORATORIES ?
| Year | Cash Earnings per Share (CEPS) |
|---|---|
| Mar2025 | 253.82 |
| Mar2024 | 280.42 |
| Mar2023 | 168.59 |
| Mar2022 | 87.97 |
| Mar2021 | 93.78 |
How is Cash Earnings per Share (CEPS) of NEULAND LABORATORIES Trending?
| Years | Cash Earnings per Share (CEPS) | % Change | |
|---|---|---|---|
| Mar2025 | 253.82 | -9.49 | |
| Mar2024 | 280.42 | 66.33 | |
| Mar2023 | 168.59 | 91.64 | |
| Mar2022 | 87.97 | -6.20 | |
| Mar2021 | 93.78 | - | |
Other Financial Ratios of NEULAND LABORATORIES
| Operational & Financial Ratios Earnings Per Share DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Cash Earnings per Share (CEPS) ratio of peers of NEULAND LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NEULAND LABORATORIES | ₹18,914.0 Cr | -1.8% | -9.3% | 3.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹415,073.0 Cr | -0% | -3.2% | -5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹175,657.0 Cr | 4% | 5.2% | 11.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹134,121.0 Cr | 3.6% | 7% | 22% | Stock Analytics | |
| CIPLA | ₹118,431.0 Cr | -3.5% | -1.5% | -2.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,944.0 Cr | -3.2% | -3.3% | -10.6% | Stock Analytics | |
NEULAND LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NEULAND LABORATORIES | -1.8% |
-9.3% |
3.7% |
| SENSEX | -2.6% |
-1.3% |
7.2% |
You may also like the below Video Courses